Halo Neuroscience is a neurotechnology company focused on human performance. Our first product, Halo Sport,
utilizes neuropriming technology to accelerate the neurologic gains of strength and skill learning that result from athletic training.
Since coming out of stealth in February 2016, the reception has been strong. Halo Sport is now live with teams and athletes from the NBA, MLB, NFL, Olympics, and U.S. Military.
The company has been covered in 500+ publications, including a feature in Sports Illustrated
that details Halo's work with NFL prospects training for the Draft.
In March 2016, Halo won the MIT Sloan Sports conference
startup competition, and Halo Sport has over 27 filed patents.
Halo has raised $9M in series A funding
from top-tier venture investors like Andreessen Horowitz, Lux Capital, SoftTech VC, and JAZZ Partners.
Our founders are neurotechnology veterans — Dr. Daniel Chao, Halo co-founder and CEO, received his MD and MS in neuroscience from Stanford.
Dr. Brett Wingeier, Halo co-founder and CTO, earned his biomedical engineering doctorate with studies at Tulane, Stanford, and Swinburne,
and is also a U.S. Registered Patent Agent named on 25 U.S. patents.